Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest StudyFrida Bugge Askeland,Einar Haukas,Tobias S. Slordahl,Anja Klostergaard, Tatjana Alexandersen,Diana Schjoll,Anna Lysen,Emil Hermansen,Fredrik SchjesvoldBLOOD(2023)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要